Clinical Trial Update: Prostate Cancer 18F-PSMA-1007 PET/CT Access Trial

View source ↗

Summary

Clinical trial update for prostate cancer shows the 18F-PSMA-1007 PET/CT Access Trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-PSMA-1007 (PSMA-1007 radiotracer)

Snippet

Sponsor: Alberta Health services | Conditions: Prostate Cancer | Status: NOT_YET_RECRUITING